Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) based on ACTH 4-10 with a C-terminal Pro-Gly-Pro extension, CAS 80714-61-0, molecular weight 813.9 Da. Research investigates its nootropic properties and effects on BDNF/NGF expression and cerebral circulation in experimental models. Research compound — for laboratory use only.
Compound Specifications
Product Details
- Compound: Semax
- Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
- Purity: >99%
- Form: Lyophilized powder
- Sizes: 5mg, 10mg
- Testing: View COA (Verified by Janoshik) →
Research Studies
(for educational purposes only)
Semax gene expression changes in ischemic stroke model
Source: PMC3987924
Summary: This genome-wide study examined Semax effects on gene expression in rat brain tissue following ischemic stroke, identifying altered expression of genes related to inflammatory response and cellular repair.
Semax derivatives and amyloid-beta interactions
Source: PMC8855339
Summary: This study investigated Semax and copper ion complexes, examining interactions with amyloid-beta and potential effects on complex formation in laboratory models.
